A microbiota intestinal e sua interface com o sistema imunológico
Gut microbiota and its interface with the immune system
Herberto J. Chong-Neto; Antonio Carlos Pastorino; Ana C. C. Della Bianca Melo; Décio Medeiros; Fábio Chigres Kuschnir; Maria Luiza Oliva Alonso; Neusa Falbo Wandalsen; Cristine Secco Rosário; Dirceu Solé; Bruno A. Paes Barreto
Resumo
A microbiota intestinal humana influencia diversos sistemas orgânicos e há evidências de sua ação sobre o sistema imunológico. O objetivo desta revisão foi verificar a influência da microbiota intestinal humana e sua interface com o sistema imunológico. A partir das palavras-chaves gut (intestino) e microbiota (microbiota), e utilizando o operador boleano AND para correlacionar a palavra-chave com os diversos temas propostos para o artigo de revisão, como por exemplo, gut microbiota AND delivery ou gut microbiota AND mode of delivery, foram selecionados artigos obtidos da busca na base PubMed, sobretudo nos últimos 10 anos (2009-2019). Há evidências de que a janela de oportunidade para intervenção e prevenção primária das doenças alérgicas começa antes do nascimento e provavelmente dentro do período fetal, estendendo-se ao tipo de parto, alimentação nos primeiros meses de vida, fatores ambientais e uso de antibióticos. Compreender esta complexa interface que envolve, por um lado a microbiota (microrganismos e seus subprodutos) e, por outro, receptores e células especializadas, é fundamental para o entendimento dos mecanismos de tolerância ou desequilíbrio imunológico, os quais estão respectivamente ligados ao estado fisiológico de saúde ou aos processos patofisiológicos de diversas doenças, sobretudo aquelas de contexto imunomediado.
Palavras-chave
Abstract
The human gut microbiota influences various organ systems, and there is evidence of its action on the immune system. The aim of this review was to determine the influence of the human gut microbiota and its interface with the immune system. The PubMed database was searched for articles published from 2009 to 2019 using the keywords “gut” and “microbiota”. The Boolean operator AND was used to combine terms in the search, such as “gut microbiota AND delivery” and “gut microbiota AND mode of delivery”. There is evidence that the window of opportunity for intervention and primary prevention of allergic diseases begins before birth, probably within the fetal period, and includes mode of delivery, early infant feeding, environmental factors, and antibiotic use. Understanding the complex interface that involves, on the one hand, the microbiota (microorganisms and their by-products) and, on the other hand, specialized receptors and cells is essential for understanding the mechanisms of tolerance and immune imbalance, which are respectively linked to the physiological health status and to the pathophysiological processes of various diseases, especially of immune-mediated diseases.
Keywords
Referências
1. Perez-Muñoz ME, Arrieta M-C, Ramer-Tait AE, Walter J. A critical assessment of the “sterile womb” and “in utero colonization” hypotheses: implications for research on the pioneer infant microbiome. Microbiome. 2017;5:48.
2. Funkhouser LJ, Bordenstein SR. Mom knows best: the universality of maternal microbial transmission. PLoS Biol. 2013;11:e1001631.
3. Kim CJ, Erez O, Edwin S, Relman DA. Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: A molecular and culture-based investigation. PLoS One. 2008;3:e3056.
4. DiGiulio DB, Romero R, Amogan HP, Kusanovic JP, Bik EM, Gotsch F, et al. Isolation of commensal bacteria from umbilical cord blood of healthy neonates born by cesarean section. Curr Microbiol. 2005;51:270‑4.
5. Dong Y, St Clair PJ, Ramzy I, Kagan-Hallet KS, Gibbs RS. A microbiologic and clinical study of placental inflammation at term. Obstet Gynecol. 1987;70:175‑82.
6. Romero R, Sirtori M, Oyarzun E, Avila C, Mazor M, Callahan R, et al. Infection and labor V. Prevalence, microbiology, and clinical significance of intraamniotic infection in women with preterm labor and intact membranes. Am J Obstet Gynecol. 1989;161:817‑24.
7. Jimenez E, Marin ML, Martin R, Odriozola JM, Olivares M, Xaus J, et al. Is meconium from healthy newborns actually sterile? Res Microbiol. 2008;159:187‑93.
8. Moles L, Gomez M, Heilig H, Bustos G, Fuentes S, de Vos W, et al. Bacterial diversity in meconium of preterm neonates and evolution of their fecal microbiota during the first month of life. PLoS One. 2013;8:e66986.
9. Perez PF, Dore J, Leclerc M, Levenez F, Benyacoub J, Serrant P, et al. Bacterial imprinting of the neonatal immune system: Lessons from maternal cells? Pediatrics. 2007;119:e724‑e732.
10. Mshvildadze M, Neu J, Shuster J, Theriaque D, Li N, Mai V. Intestinal microbial ecology in premature infants assessed with non-culturebased techniques. J Pediatr. 2010;156:20‑5.
11. Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA. 2010;107:11971‑5.
12. Aagaard K, Ma J, Antony KM, Ganu R, Petrosino J, Versalovic J. The placenta harbors a unique microbiome. Sci Transl Med. 2014;6:237ra65.
13. Donnet-Hughes A, Perez PF, Doré J, Leclerc M, Levenez F, Benyacoub J, et al. Potential role of the intestinal microbiota of the mother in neonatal immune education. Proc Nutr Soc. 2010;69:407‑15.
14. Rescigno M, Urbano M, Valzasina B, Francolini M, Rotta G, Bonasio R, et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol. 2001;2:361‑7.
15. Ismail IH, Licciardi PV, Tang ML. Probiotic effects in allergic disease. J Paediatr Child Health. 2013;49:709‑15.
16. Ege MJ, Bieli C, Frei R, van Strien RT, Riedler J, Ublagger E; Parsifal Study team, et al. Prenatal farm exposure is related to the expression of receptors of the innate immunity and to atopic sensitization in school-age children. J Allergy Clin Immunol. 2006;117:817‑23.
17. Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo controled trial. Lancet. 2001;357:1076‑9.
18. Kukkonen K, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, et al. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol. 2007;119:192‑8.
19. Rautava S, Kainonen E, Salminen S, Isolauri E. Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant. J Allergy Clin Immunol. 2012;130:1355‑60.
20. Boyle RJ, Ismail IH, Kivivuori S, Licciardi PV, Robins-Browne RM, Mah LJ, et al. Lactobacillus GG treatment during pregnancy for the prevention of eczema: a randomized controlled trial. Allergy. 2011;66:509‑16.
21. Taylor AL, Dunstan JA, Prescott SL. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in highrisk children: a randomized controlled trial. J Allergy Clin Immunol. 2007;119:184‑91.
22. Jenmalm MC, Duchén K. Timing of allergy-preventive and immunomodulatory dietary interventions – are prenatal, perinatal or postnatal strategies optimal? Clin Exp Allergy. 2013;43:273‑8.
23. Bäckhed F, Roswall J, Peng Y, Feng Q, Jia H, KovatchevaDatchary P, et al. Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life. Cell Host Microbe. 2015;17(5):690‑703.
24. Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics. 2006;118(2):511‑21.
25. Jakobsson HE, Abrahamsson TR, Jenmalm MC, Harris K, Quince C, Jernberg C, et al. Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by caesarean section. Gut. 2014;63(4):559‑66.
26. Biasucci G, Benenati B, Morelli L, Bessi E, Boehm G. Cesarean delivery may affect the early biodiversity of intestinal bacteria. J Nutr. 2008;138:1796Se800.
27. Olszak T, An D, Zeissig S, Vera MP, Richter J, Franke A, et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science. 2012;336:489‑93.
28. Pistiner M, Gold DR, Abdulkerim H, Hoffman E, Celedon JC. Birth by cesarean section, allergic rhinitis, and allergic sensitization among children with a parental history of atopy. J Allergy Clin Immunol. 2008;122:274‑9.
29. Huh SY, Rifas-Shiman SL, Zera CA, Edwards JW, Oken E, Weiss ST, et al. Delivery by caesarean section and risk of obesity in preschool age children: a prospective cohort study. Arch Dis Child. 2012;97:610‑6.
30. Sevelsted A, Stokholm J, Bonnelykke K, Bisgaard H. Cesarean section and chronic immune disorders. Pediatrics. 2015;135:e92‑e98.
31. Hansen CH, Andersen LS, Krych L, Metzdorff SB, Hasselby JP, Skov S, et al. Mode of delivery shapes gut colonization pattern and modulates regulatory immunity in mice. J Immunol. 2014;193(3):1213‑22.
32. Zachariassen LF, Krych L, Rasmussen SH, Nielsen DS, Kot W, Holm TL, et al. Cesarean section induces microbiota-regulated immune disturbances in C57BL/6 mice. J Immunol. 2019;202(1):142‑50.
33. Walker WA. The importance of appropriate initial bacterial colonization of the intestine in newborn, child, and adult health. Pediatr Res. 2017;82(3):387‑95.
34. Gibbons L. The global numbers and costs of additionally needed and unnecessary caesarean sections performed per year: overuse as a barrier to universal coverage. World Health Report. 2010;30.
35. Finger C. Caesarean section rates skyrocket in Brazil. Many women are opting for caesareans in the belief that it is a practical solution. Lancet. 2003;362:628.
36. Bjorksten B, Sepp E, Julge K, Voor T, Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol. 2001;108(4):516‑20.
37. Sjögren YM, Jenmalm MC, Böttcher MF, Björkstén B, SverremarkEkström E. Altered early infant gut microbiota in children developing allergy up to 5 years of age. Clin Exp Allergy. 2009;39(4):518‑26.
38. Abrahamsson TR, Jakobsson HE, Andersson AF, Björkstén B, Engstrand L, Jenmalm MC, et al. Low diversity of the gut microbiota in infants with atopic eczema. J Allergy Clin Immunol. 2012;129(2):434‑40.
39. Kim H, Sitarik AR, Woodcroft K, Johnson CC, Zoratti E. Birth mode, breastfeeding, pet exposure, and antibiotic use: associations with the gut microbiome and sensitization in children. Current Allergy and Asthma Reports. 2019;19:22.
40. Abrahamsson TR, Wu RY, Jenmalm MC. Gut microbiota and allergy: the importance of the pregnancy period. Pediatr Res. 2015;77(1- 2):214‑9.
41. Michel S, Busato F, Genuneit J, Pekkanen J, Dalphin JC, Riedler J, et al. Farm exposure and time trends in early childhood may influence DNA methylation in genes related to asthma and allergy. Allergy. 2013;68 (3):35564.
42. Wold AE. The hygiene hypothesis revised: Is the rising frequency of allergy due to changes in the intestinal flora? Allergy. 1998;53 (46 Suppl):20‑5.
43. Noverr MC, Huffnagle GB. The ‘microflora hypothesis’ of allergic diseases. Clin Exp Allergy. 2005;35:1511‑20.
44. Kalliomaki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J. Allergy Clin. Immunol. 2001;107:129‑34.
45. Penders J, Stobberingh EE, Thijs C, Adams H, Vink C, van Ree R, et al. Molecular fingerprinting of the intestinal microbiota of infants in whom atopic eczema was or was not developing. Clin Exp Allergy. 2006;36:1602‑8.
46. Penders J, Thijs C, van den Brandt PA, Kummeling I, Snijders B, Stelma F, et al. Gut microbiota composition and development of atopic manifestations in infancy: The KOALA Birth Cohort Study. Gut. 2007;56:661‑7.
47. Tissier H. Recherches sur la flore intestinale des nourrissons (état normal et pathologique). Paris: G. Carre and C. Naud, 1900.
48. Jiménez E, Marín ML, Martín R, Odriozola JM, Olivares M, Xaus J, et al. Is meconium from healthy newborns actually sterile? Res Microbiol. 2008;1(59):187‑93.
49. Jiménez E, Fernández L, Marín ML, Odriozola JM, Olivares M, Xaus J, et al. Isolation of commensal bacteria from umbilical cord blood of healthy neonates born by cesarean section. Curr Microbiol. 2005;51:270‑4.
50. Satokari R, Grönroos T, Laitinen K, Salminen S, Isolauri E. Bifidobacterium and Lactobacillus DNA in the human placenta. Lett Appl Microbiol. 2009;48:8‑12.
51. Gibbs RS, Blanco JD, St Clair PJ, Castaneda YS. Quantitative bacteriology of amniotic fluid from women with clinical intraamniotic infection at term. J Infect Dis. 1982;145:1‑8.
52. DiGiulio DB, Romero R, Kusanovic JP, Gomez R, Kim CJ, Seok KS, et al. Prevalence and diversity of microbes in the amniotic fluid, the fetal inflammatory response, and pregnancy outcome in women with preterm pre-labor rupture of membranes. Am J Reprod Immunol. 2010;64:38‑57.
53. Roos PJ, Malan AF, Woods DL, Botha P, Hyland J, Heese H de V. The bacteriological environment of preterm infants. S Afr Med J. 1980;57:347‑50.
54. DiGiulio DB, Romero R, Amogan HP, Kusanovic JP, Bik EM, Gotsch F, et al. Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: A molecular and culture-based investigation. PLoS One. 2008;3:e3056.
55. Koren O, Goodrich JK, Cullender TC, Spor A, Laitinen K, Bäckhed HK, et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell. 2012;150:470‑80.
56. Mitsuoka T. Development of functional foods. Biosci Microbiota Food Health. 2014;33:117e28.
57. Valles Y, Artacho A, Pascual-García A, Ferrús ML, Gosalbes MJ, Abellán JJ, et al. Microbial succession in the gut: directional trends of taxonomic and functional change in a birth cohort of Spanish infants. PLoS Genet. 2014;10:e1004406.
58. Palmer C, Bik EM, Di Giulio DB, Relman DA, Brown PO. Development of the human infant intestinal microbiota. PLoS Biol. 2007;5:1556e73.
59. Bager P, Wohlfahrt J, Westergaard T. Caesarean delivery and risk of atopy and allergic disease: meta-analyses. Clin Exp Allergy. 2008;38:634‑42.
60. Hanski I, von Hertzen L, Fyhrquist N, Koskinen K, Torppa K, Laatikainen T, et al. Environmental biodiversity, human microbiota, and allergy are interrelated. Proc Natl Acad Sci USA. 2012;109:8334‑9.
61. Song SJ, Lauber C, Costello EK. Cohabiting family members share microbiota with one another and with their dogs. Elife. 2013;2:e00458.
62. Lynch SV, Wood RA, Boushey H, Lozupone CA, Humphrey G, Berg-Lyons D, et al. Effects of early-life exposure to allergens and bacteria on recurrent wheeze and atopy in urban children. J Allergy Clin Immunol. 2014;134(3):593-601.
63. Lynch SV. The lung microbiome and airway disease. Ann Am Thoracic Soc. 2016;13(5):S462-5.
64. Huang YJ, Nariya S, Harris JM, Lynch SV, Choy DF, Arron J, et al. The airway microbiome in patients with severe asthma: associations with disease features and severity. J Allergy Clin Immunol. 2015;136:874‑84.
65. Goldman DL, Chen Z, Shankar V, Tyberg M, Vicencio A, Burk R. Lower airway microbiota and mycobiota in children with severe asthma. J Allergy Clin Immunol. 2018;141(2):808-10.
66. Thaiss CA, Zeevi D, Levy M, Zilberman-Schapira G, Suez J, Tengeler AC, et al. Transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis. Cell. 2014;159:514-29.
67. Huang YJ, Boushey HA. The microbiome in asthma. J Allergy Clin Immunol. 2015;135(1):25-30.
68. Wypych TP, Wickramasinghe LC, Marsland BJ. The influence of the microbiome on respiratory health. Nat Immunol. 2019;20(10):1279‑90.
69. Zhang Q, Cox M, Liang Z, Brinkmann F, Cardenas PA, Duff R, et al. Airway Microbiota in Severe Asthma and Relationship to Asthma Severity and Phenotypes. PLoS One. 2016 Apr 14;11(4):e0152724.
70. Bisgaard H, Hermansen MN, Buchvald F, Loland L, Halkjaer LB, Bønnelykke K, et al. Childhood asthma after bacterial colonization of the airway in neonates. N Engl J Med. 2007;357:1487‑95.
71. Bisgaard H, Hermansen MN, Bønnelykke K, Stokholm J, Baty F, Skytt NL, et al. Association of bacteria and viruses with wheezing episodes in young children: prospective birth cohort study. BMJ. 2010;341:c4978.
72. Huang YJ, Nelson CE, Brodie EL, Desantis TZ, Baek MS, Liu J, et al. Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol. 2011;127:372-81.
73. Smits HH, van der Vlugt LEPM, von Mutius E, Hiemstra PS. Childhood allergies and asthma: New insights on environmental exposures and local immunity at the lung barrier. Current Opinion in Immunology. 2016;42:41‑7.
74. Holt PG. The mechanism or mechanisms driving atopic asthma initiation: the infant respiratory microbiome moves to center stage. J Allergy Clin Immunol. 2015;136:15-22.
75. Beck JM, Young VB, Huffnagle GB. The microbiome of the lung. Transl Res. 2012;160(4):258-66.
76. Frati F, Salvatori C, Incorvaia C, Bellucci A, Di Cara G, Marcucci F, et al. The role of the microbiome in asthma: the gut-lung axis. Int J Mol Sci. 2019;20:123.
77. Faner R, Sibila O, Agustí A, Bernasconi E, Chalmers JD, Huffnagle GB, et al. The microbiome in respiratory medicine: current challenges and future perspectives. Eur Respir J. 2017;49:1602086.
78. Yamazaki Y, Nakamura Y, Nuñez G. Role of the microbiota in skin immunity and atopic dermatitis. Allergology International. 2017;66:539-44.
79. Lynde CW, Andriessen A, Bertucci V, McCuaig C, Skotnicki S, Weinstein M, et al. The Skin Microbiome in Atopic Dermatitis and Its Relationship to Emollients. J Cutan Med Surg. 2016;20(1):21-8.
80. Baldwin HE, Bhatia ND, Friedman A, Eng RM, Seité S. The role of cutaneous microbiota harmony in maintaining a functional skin barrier. J Drugs Dermatol. 2017;16(1):12-8.
81. Powers CE, McShane DB, Gilligan PH, Burkhart CN, Morrell DS. Microbiome and pediatric atopic dermatitis. J Dermatol. 2015;42(12):1137-42.
82. Reginald K, Westritschnig K, Werfel T, Heratizadeh A, Novak N, Focke-Tejkl M, et al. Immunoglobulin E antibody reactivity to bacterial antigens in atopic dermatitis patients. Clin Exp Allergy. 2011;41:357e69.
83. Stiemsma LT, Michels KB. The Role of the Microbiome in the Developmental Origins of Health and Disease. Pediatrics. 2018;141(4):e20172437.
84. Indrio F, Martini S, Francavilla R, Corvaglia L, Cristofori F, Mastrolia AS, et al. Epigenetic Matters: The Link between Early Nutrition, Microbiome, and Long-term Health Development. Front Pediatr. 2017;5:178.
85. Zhang Q, Cao X. Epigenetic regulation of the innate immune response to infection. Nat Rev Immunol. 2019;19:417-32.
86. Gilbert SF. A holobiont birth narrative: the epigenetic transmission of the human microbiome. Front Genet. 2014;19(5):282.
87. Lambrecht BN, Hammad H. The immunology of the allergy epidemic and the hygiene hypothesis. Nature Immunology. 2017;18(10):1076-83.
88. Silveira PP, Portella AK, Goldani MZ, Barbieri MA. Developmental origins of health and disease (DOHaD). J Pediatr (Rio J). 2007;83(6):494-504.
89. Brands B, Poston I, Godfrey K, Demmelmair H. Early Nutrition Project. Early nutrition programming of longterm health. Proc Nutr Soc. 2012;71:371-8.
90. American Academy of Pediatrics: Policy Statement: breastfeeding and the use of human milk. Pediatrics. 2012;129:e827-e841.
91. Voreades N, Kozil A, Weir T. Diet and the development of the human intestinal microbiome. Front Microbiol. 2014 Sep 22;5:494. doi: 10.3389/fmicb.2014.00494. eCollection 2014.
92. Bergström A, Skov T, Bahl M, Roager H, Christensen I, Ejlerskov K, et al. Establishment of intestinalvmicrobiota during early life: a longitudinal, explorative study of a large cohort of Danish infants. Appl Environ Microbiol. 2014;80:2889-900.
93. Turroni F, Peano C, Pass D, Foroni E, Severgnini M, Claesson M, et al. Diversity of bifidobacteria within the infant gut microbioma. PloS ONE 7. 2012;e36957.doi:10.1371/journal.pone.0036957.
94. Hansen H, Wildeboer-Veloso A, Raangs G, Waendorp A, Klijn N, Bindels J, et al. Analisys of intestinal flora development in breastfed and formula-fed infants by using molecularidentification and detection methods. J Pediatr Gastroenterol Nutr. 2000;30:61-7.
95. Fallani M, Young D, Scott J, Norin E, Amauri S, Adam R, et al. Intestinal microbiota of 6-week-old infants across Europe: geografic influence beyond delivery mode, breast- feeding and antibiotics. J Pediatr Gastroenterol Nutr. 2010;51:77-84.
96. Stark P, Lee A. The microbial ecology of the large bowel of breast-fed and formula-fed infants during the first year of life. J Med Microbiol. 1982;15:189-203.
97. Palma G, Capilla A, Nova E, Castillejo G, Varea V, Pozo T, et al. Influence of milk-feeding type and genetics: risk of developing coeliac disease on intestinal microbiota of infants: the PROFICEL study. PloS ONE 7. 2012;e30791.
98. Kramer M. Breastfeeding and allergy: the evidence. Ann Nutr Metab. 2010;59:20-6.
99. Sjogren Y, Tominic S, Lundberg A, Böttcher M, Björkstén B, Sverremark-Ekström E, et al. Influence of early gut microbiota on the maturation of childhood mucosal and systemic imune responses. Clin Exp Allergy. 2009;39:1842-51.
100. Wise A, Robertson B, Choudhury B, Rautava S, Isolauri E, Salminen S, et al. Infants Are Exposed to Human Milk Oligosaccharides Already in utero. Front Pediatr. 2018;6:270.
101. Donovan SM, Wang M, Li M, Friedberg I, Schwartz SL, Chapkin RS. Host-microbe interactions in the neonatal intestine: role of human milk oligosaccharides. Adv Nutr. 2012;3(3):450S-5S.
102. Donovan SM, Comstock SS. Human Milk Oligosaccharides Influence Neonatal Mucosal and Systemic Immunity. Ann Nutr Metab. 2016;69 Suppl 2:42-51. doi:10.1159/000452818.
103. Davis JC, Totten SM, Huang JO, Nagshbandi S, Kirmiz N, Garrido DA, et al. Identification of Oligosaccharides in Feces of Breast-fed Infants and Their Correlation with the Gut Microbial Community. Mol Cell Proteomics. 2016;15(9):2987-3002.
104. Puccio G, Alliet P, Cajozzo C, Janssens E, Corsello G, Sprenger N, et al. Effects of Infant Formula with Human Milk Oligosaccharides on Growth and Morbidity: A Randomized Multicenter Trial. J Pediatr Gastroenterol Nutr. 2017;64(4):624-31.
105. Strzepa A, Lobo FM, Majewska-Szczepanik M, Szczepanik M. Antibiotics and autoimune and Allergy diseases: causative factor or treatment? Intern Immunopharmacol. 2018;65:328-41.
106. Zwittink RD, Renes IB, van Lingen RA, van Zoeren-Grobben D, Konstanti P, Norbruis OF, et al. Association between duration of intravenous antibiotic administration and early-life mi- crobiota development in late-preterm infants. Eur J Clin Microbiol Infect Dis. 2018;37:475‑83.
107. ACOG. Committee Opinion No. 485: Prevention of early-onset group B streptococcal disease in newborns. Obstet Gynecol. 2011;117:1019‑27.
108. Stearns JC, Simioni J, Gunn E, McDonald H, Holloway AC, Thabane L, et al. Intrapartum antibiotics for GBS prophylaxis alter colonization patterns in the early infant gut microbiome of low risk infants. Sci Rep. 2017;7(1):16527.
109. Aloisio I, Quagliariello A, De Fanti S, Luiselli D, De Filippo C, Albanese D, et al. Evaluation of the effects of intrapartum antibiotic prophylaxis on newborn intestinal micro- biota using a sequencing approach targeted to multi hypervariable 16S rDNA regions. Appl Microbiol Biotechnol. 2016;100:5537‑46.
110. Nogacka A, Salazar N, Suárez M, Milani C, Arboleya S, Solís G, et al. Impact of intrapartum antimicrobial prophylaxis upon the intestinal microbiota and the prevalence of antibiotic resistance genes in vaginally delivered full-term neonates. Microbiome. 2017;5:93.
111. Martin R, Makino H, Cetinyurek Yavuz A, Ben-Amor K, Roelofs M, Ishikawa E, et al. Early-Life Events, Including Mode of Delivery and Type of Feeding, Siblings and Gender, Shape the Developing Gut Microbiota. PLoS One. 2016;11:e0158498.
112. Tejada BM. Antibiotic use and misuse during pregnancy and delivery: benefits and risks, Int J Environ Res Public Health. 2014;11:7993‑8009.
113. Langdon A, Crook N, Dantas G. The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation. Genome Med. 2016;8:39.
114. McKeever TM, Lewis SA, Smith C, Collins J, Heatlie H, Frischer M, et al. Early exposure to infections and an- tibiotics and the incidence of allergic disease: a birth cohort study with the West Midlands General Practice Research Database, J Allergy Clin Immunol. 2002;109:43‑50.
115. McKeever TM, Lewis SA, Smith C, Hubbard R. The importance of prenatal exposures on the development of allergic disease: a birth cohort study using the West Midlands General Practice Database. Am J Respir Crit Care Med. 2002;166:827‑32.
116. Farooqi IS, Hopkin JM. Early childhood infection and atopic disorder. Thorax. 1998;53:927‑32.
117. Yamamoto-Hanada K, Yang L, Narita M, Saito H, Ohya Y. Influence of antibiotic use in early childhood on asthma and allergic diseases at age 5. Ann Allergy Asthma Immunol. 2017;119:54‑8.
118. Cohet C, Cheng S, MacDonald C, Baker M, Foliaki S, Huntington N, et al. Infections, medication use, and the prevalence of symptoms of asthma, rhinitis, and eczema in childhood. J Epidemiol Community Health. 2004;58:852‑7.
119. Wickens K, Pearce N, Crane J, Beasley R. Antibiotic use in early childhood and the development of asthma. Clin. Exp Allergy. 1999;29:766‑71.
120. Celedon JC, Litonjua AA, Ryan L, Weiss ST, Gold DR. Lack of association between antibiotic use in the first year of life and asthma, allergic rhinitis, or eczema at age 5 years. Am J Respir Crit Care Med. 2002;166:72‑5.
121. Foliaki Pearce SN, Bjorksten B, Mallol J, Montefort S, von Mutius E. Antibiotic use in infancy and symptoms of asthma, rhinoconjunctivitis, and eczema in children 6 and 7 years old: International Study of Asthma and Allergies in Childhood Phase III. J Allergy Clin Immunol. 2009;124:982‑9
Submetido em:
22/07/2019
Aceito em:
28/08/2019
Facebook
LinkedIn
Mendeley
StumbleUpon
Reddit
Email